About
Cell Therapy Platform for Oncology
Areas of Focus
Categories
Stem Cell & Cellular TherapyNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
20
By Phase
PHASE1: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04901416Lead Sponsor
Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS
PHASE1Completed
8 participants
Started: Dec 15, 2021 · Completed: Jun 4, 2024
NCT04900454Lead Sponsor
Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19
PHASE1Completed
12 participants
Started: Aug 1, 2021 · Completed: Jul 1, 2022
Locations (1)
Headquarters
Wexford, PA, United States
Map
Loading map...